|
|
End of day quotes updated Fri Oct 11 15:49 CST
🏠
🔍
|
| 11-Oct-2024 |
31.92 |
+1.93 {+6.4 %} |
V: 1,565,613 |
|
| EWTX |
11-Oct-2024 |
Close: 31.92 |
+1.93 {+6.4 %} |
Volume: 1,565,613 |
|
|
Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc.
|
|
|
|
|
|
|
06-Aug-2024
05-Jan-2024
29-Dec-2023
|
|
|
|
|
|
EWTX
|
SPY
|
|
6.4
12.4
19.6
19.6
191.8
|
0.6
1.2
1.0
1.0
22.7
|
|
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
|
SPY tracks S&P 500 index.
|
|
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
|
| EWTX News | 17-Sep-2024 3:01 PM CST - Business Wire
Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that members of the management team will hold a live webcast to discuss top-line data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm of the Phase 2 CIRRUS-HCM trial in patients with obstructive HCM on Thursday, September 19, 2024, at 8:30 am ET. The team will be joined by CIRRUS-HCM investigator, Anjali T. Owens, M.D., | | | |
Disclaimer
Privacy
Contact
Copyright © 2001-2024, All rights reserved.
HotCandlestick.com, LLC
|
